Charles J. Ryan

ORCID: 0000-0002-2081-3557

Also affiliated with Memorial Sloan Kettering Cancer Center, University of Minnesota Medical Center, Minnesota Oncology

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 18 papers. Top paper: “Testicular Cancer, Version 2.2015”.

Testicular Cancer, Version 2.2015

Journal of the National Comprehensive Cancer Network(2015)10.6004/jnccn.2015.0092

N/A

0.732DataRank · unranked

131 citations

Eric Jonasch, Neeraj Agarwal, Clair Beard, Sam Bhayani, Graeme B. Bolger +27 more

AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patients

Nature Communications(2024)10.1038/s41467-024-54847-1

N/A

0.571DataRank · unranked

21 citations

Bin Luo, Anna Kobilka, J. Lyman, Siyuan Guo, Sarah A. Munro +11 more

Quality of life for men with metastatic castrate-resistant prostate cancer participating in an aerobic and resistance exercise pilot intervention

Urologic Oncology Seminars and Original Investigations(2022)10.1016/j.urolonc.2022.11.016

N/A

0.457DataRank · unranked

20 citations

Yea‐Hung Chen, Erin L. Van Blarigan, June M. Chan, Charles J. Ryan, Li Zhang +16 more

Regulatory genes in the androgen production, uptake and conversion (APUC) pathway in advanced prostate cancer

Endocrine Oncology(2022)10.1530/eo-22-0058

N/A

0.292DataRank · unranked

6 citations

Hannah E. Bergom, Anna E. Prizment, Susan Halabi, Nima Sharifi, Charles J. Ryan +2 more

External Validation of a Prognostic Model of Overall Survival in Men With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer

Journal of Clinical Oncology(2023)10.1200/jco.22.02661

N/A

0DataRank · unranked

29 citations

Qian Yang, Akash Roy, Bin Luo, John C. Araujo, Christopher J. Logothetis +15 more

Molecular analysis of primary and metastatic sites in patients with renal cell carcinoma

Journal of Clinical Investigation(2024)10.1172/jci176230

N/A

0DataRank · unranked

31 citations

Pedro C. Barata, Andrew Elliott, Mehmet Asım Bilen, Earle F. Burgess, Toni K. Choueiri +16 more

Prostate Cancer Mortality Associated with Aggregate Polymorphisms in Androgen-Regulating Genes: The Atherosclerosis Risk in the Communities (ARIC) Study

Cancers(2021)10.3390/cancers13081958

N/A

0DataRank · unranked

14 citations

Sean McSweeney, Nathan Pankratz, Corinne E. Joshu, Justin H. Hwang, Elizabeth A. Platz +2 more

Expression Patterns of DLL3 across Neuroendocrine and Non-neuroendocrine Neoplasms Reveal Broad Opportunities for Therapeutic Targeting

Cancer Research Communications(2025)10.1158/2767-9764.crc-24-0501

N/A

0DataRank · unranked

14 citations

Andrew Elliott, Mark G. Evans, James Wacker, Kathleen M. Storey, Emily A. Egusa +14 more

Safety and tolerability of RPESC-RPE transplantation in patients with dry age-related macular degeneration: Low-dose clinical outcomes

Cell stem cell(2025)10.1016/j.stem.2025.08.012

N/A

0DataRank · unranked

9 citations

Brigitte L. Arduini, Susan L. Borden, Dhruv Sareen, Clive N. Svendsen, Paul P. Lee +11 more

Pathogenic Genomic Alterations in Circulating Tumor DNA Predict Overall Survival in Men with Metastatic Castrate-resistant Prostate Cancer

European Urology(2025)10.1016/j.eururo.2025.07.011

N/A

0DataRank · unranked

5 citations

Siyuan Guo, Bin Luo, Chenxi Yu, Todd P. Knutson, Anna Kobilka +13 more

Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancer

npj Precision Oncology(2025)10.1038/s41698-025-01002-8

N/A

0DataRank · unranked

1 citations

Ya‐Mei Hu, Joel A. Yates, Chao Zhang, Eva S. Rodansky, Dhruv Khokhani +26 more

The Influence of the Germline HSD3B1 Adrenal-Permissive Allele (c.1100 C) on the Somatic Alteration Landscape, the Transcriptome, and Immune Cell Infiltration in Prostate Cancer

Cancers(2025)10.3390/cancers17081270

N/A

0DataRank · unranked

1 citations

Allison Makovec, Carly D. Miller, Shayan Nazari, Andrew Elliott, Aiden Deacon +10 more

Genetic Drivers of Quality of Life in Prostate Cancer: An Evaluation of Genetic Polymorphisms and Patient-reported Outcomes in the E3805 CHAARTED trial

European Urology Oncology(2025)10.1016/j.euo.2025.04.003

N/A

0DataRank · unranked

1 citations

Xiangying Chu, Charles J. Ryan, Arjun Gupta, Christopher J. Sweeney, David F. Jarrard +10 more

Racial differences in organic anion transport proteins (OATP) and outcome in castration resistant prostate cancer treated with AR pathway inhibitors in Alliance A031201: A phase III trial.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.5_suppl.246

N/A

0DataRank · unranked

0 citations

Hyotae Kim, Michael J. Morris, Mohammad Alyamani, Roberto Diaz, Himisha Beltran +4 more

Androgen production, uptake, and conversion (APUC) genes define prostate cancer patients with distinct clinical outcomes

JCI Insight(2024)10.1172/jci.insight.183158

N/A

0DataRank · unranked

5 citations

Ella Boytim, Sean McSweeney, Negar Sadeghipour, Andrew Elliott, Rachel Passow +11 more

Alliance A031902 (CASPAR): A randomized, phase (ph) 3 trial of enzalutamide with rucaparib/placebo as novel therapy in first-line metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.tps194

N/A

0DataRank · unranked

5 citations

Glenn Heller, Charles J. Ryan, David James VanderWeele, Lionel D. Lewis, Alan Tan +10 more

Alliance A031902 (CASPAR): A randomized, phase (ph) 3 trial of enzalutamide with rucaparib/placebo in first-line metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps5107

N/A

0DataRank · unranked

4 citations

Glenn Heller, Charles J. Ryan, David James VanderWeele, Lionel D. Lewis, Alan Tan +10 more

Molecular correlates of high B7-H3-expressing metastatic castrate-resistant prostate cancers (mCRPC) via exome, transcriptome, and epigenome analyses.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.5045

N/A

0DataRank · unranked

1 citations

Abderrahman Day, Hannah E. Bergom, Sydney Tape, Sylvan C. Baca, Charles J. Ryan +4 more